Results 221 to 230 of about 180,947 (337)

Peripheral blood cytokine levels in paediatric‐onset inflammatory bowel disease: A systematic review and meta‐analysis

open access: yesJPGN Reports, EarlyView.
Abstract Objectives We aimed to summarise findings on blood cytokine levels in patients with paediatric‐onset inflammatory bowel disease (PIBD) compared to healthy controls. Methods This systematic review followed the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta‐Analyses) guidelines and was registered at Prospero (CRD42024579684 ...
Sabine Jansson   +7 more
wiley   +1 more source

A Rare Presentation of Crohn's Disease: A Case Report. [PDF]

open access: yesCureus
Marques Ferreira I   +4 more
europepmc   +1 more source

Assessing attitudes, access, barriers, and facilitators to multidisciplinary care in pediatric inflammatory bowel disease

open access: yesJPGN Reports, EarlyView.
Abstract Objective Multidisciplinary care is recommended for pediatric inflammatory bowel disease (IBD). This study aims to describe provider attitudes, barriers, and facilitators regarding multidisciplinary care in pediatric IBD, and explore associations between multidisciplinary care access and center‐level factors.
Nicole Davidson   +6 more
wiley   +1 more source

The Impact of Sarcopenia on Clinical Outcomes in Pediatric Crohn's Disease. [PDF]

open access: yesInflamm Bowel Dis
D'Arcangelo G   +6 more
europepmc   +1 more source

P428 Long-term outcomes of endoscopic ballon dilation for small-bowl strictures using double balloon enteroscopy in patients with Crohn’s disease [PDF]

open access: bronze, 2019
Teruyuki Takeda   +6 more
openalex   +1 more source

Crohn’s disease with acute gastrointestinal bleeding caused by perianal fistula: a case description

open access: diamond, 2023
Duo Xu   +6 more
openalex   +1 more source

Severe allergic reaction to ustekinumab reinitiation in a pediatric patient with Crohn's disease: A case report

open access: yesJPGN Reports, EarlyView.
Abstract Ustekinumab (UST) is a monoclonal antibody used in the management of moderate to severe inflammatory bowel disease. While generally well‐tolerated, serious adverse reactions, including hypersensitivity and anaphylaxis, have been documented, specifical following the initial intravenous (IV) dose.
Kennedy Sparling   +2 more
wiley   +1 more source

Home - About - Disclaimer - Privacy